ArticleMethodsX2026
BRAIN-META: A reproducible CNN-vision transformer meta-ensemble pipeline for explainable brain tumor classification.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A Hybrid Approach for Brain-Tumor Detection and Classification from MRI Images.Journal of imaging · 2026Article
- A multi-level attention CNN-transformer based framework for the detection of brain tumor using regional dual-score explainability.Scientific reports · 2026Article
- A multimodal fusion model integrating Vision Transformer, radiomics, and clinical features for predicting bone metastasis in prostate cancer.Frontiers in oncology · 2026Article
- BrainFusionNet: an attention-augmented deep convolutional framework with hybrid loss optimisation and test-time augmentation for multi-class brain tumour detection in magnetic resonance images.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents BRAIN-META, a reproducible deep learning methodology designed for multi-class brain tumor classification using structural MRI. The proposed approach combines ten hybrid CNN-Vision Transformer (ViT) models with a meta-learning ensemble framework. The dataset includes 2D MRI images representing four tumor categories: glioma, meningioma, pituitary, and notumor. A standardized preprocessing pipeline involving image resizing, normalization, and CLAHE (Contrast Limited Adaptive Histogram Equalization) is applied to improve image quality and feature visibility. Ten pre-trained CNN architectures-DenseNet121, DenseNet169, DenseNet201, MobileNet, MobileNetV2, EfficientNetB0, EfficientNetB1, EfficientNetB4, InceptionV3, and Xception-are fused with Vision Transformer blocks to extract both local and global features. Each CNN-ViT model is trained independently, and the softmax outputs from validation data are used to generate stacked feature vectors. These vectors are input to two meta-learners, Logistic Regression and XGBoost, which are trained to produce final predictions. Evaluation metrics include accuracy, precision, recall, F1-score, and confusion matrix. XGBoost meta-learner achieved the highest accuracy of 97.10%, followed by Logistic Regression meta-learner at 97.03%, outperforming all individual base models. To enhance interpretability, Grad-CAM was employed, visually highlighting regions influencing classification. The proposed method is accurate, explainable, and modular, making it a strong candidate for clinical decision support in neuro-oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.